Thrombocytopenia: all 703 studies

Page 2 of 8. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.

• The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LITRecruitingNCT05944445
• Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid LeukemiaNot yet recruitingNCT05944211Phase 2
• High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized TrialRecruitingNCT05943691Phase 2
• OBS'CEREVANCE: French Cohort of Pediatric Autoimmune CytopeniaRecruitingNCT05937828
• Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune ThrombocytopeniaRecruitingNCT05932524Phase 2
• Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune NeutropeniaRecruitingNCT05931718
• CNCT19 Cell Injection for Refractory Systemic Lupus ErythematosusEnrolling by invitationNCT05930314Early Phase 1
• Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With ThrombocytopeniaNot yet recruitingNCT05929248Phase 2
• Immune Thrombocytopenia Management in AdultsRecruitingNCT05861297Phase 4
• Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT05852847Phase 2
• TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)RecruitingNCT05718856Phase 4
• Platelet-Directed Whole Blood Transfusion Strategy for MalariaRecruitingNCT05711485Not applicable
• Biologic Characterization of Patients With ITPRecruitingNCT05694325Not applicable
• Frequency and Severity of Thrombocytopenia in Neonatal SepsisNot yet recruitingNCT05692128
• Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in BrazilRecruitingNCT05630313
• Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)RecruitingNCT05604859Phase 4
• Short-course High-dose Prednisone and Dexamethasone in Children With ITPRecruitingNCT05522465Phase 4
• Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in ChildrenRecruitingNCT05520892Phase 4
• Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune ThrombocytopeniaNot yet recruitingNCT05459649Phase 2
• Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before HepatectomyRecruitingNCT05442632Phase 2
• Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac InjuryRecruitingNCT05411705Phase 4
• Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential ThrombocythemiaRecruitingNCT05395507Phase 2
• Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune ThrombocytopeniaNot yet recruitingNCT05369377Phase 2
• The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaNot yet recruitingNCT05369364Phase 2
• Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune ThrombocytopeniaRecruitingNCT05338190Phase 3
• An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AANot yet recruitingNCT05333861
• STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisRecruitingNCT05255003Phase 4
• Herombopag for Chemotherapy-induced ThrombocytopeniaRecruitingNCT05236582Phase 2
• Avatrombopag for Chemotherapy-induced ThrombocytopeniaRecruitingNCT05218226Phase 2
• A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune ThrombocytopeniaRecruitingNCT05214391Phase 2
• Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary ThrombocytopeniaRecruitingNCT05199909Phase 2
• AZA Combined With NAC for PIT After HSCTNot yet recruitingNCT05126004Phase 2
• Function of Platelets Used for TransfusionsEnrolling by invitationNCT05038722
• A Study of Elritercept Alone or Together With Ruxolitinib in Adults With MyelofibrosisRecruitingNCT05037760Phase 2
• IgIV Plus Prednisone vs High-dose Dexamethasone for ITPRecruitingNCT04968899Phase 3
• TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With AutoantibodiesRecruitingNCT04915482Phase 2/3
• TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 YearsRecruitingNCT04890041Not applicable
• Managed Access Programs for ETB115, EltrombopagAvailableNCT04837703
• Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at DiagnosisRecruitingNCT04800458Not applicable
• Eltrombopag for Chemotherapy-induced ThrombocytopeniaRecruitingNCT04600960Phase 2
• The Neonatal Hemorrhagic Risk Assessment in ThrombocytopeniaRecruitingNCT04598750
• Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)RecruitingNCT04304820Phase 2Results posted
• Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential ThrombocythemiaRecruitingNCT04226950Phase 2
• Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune CytopeniaRecruitingNCT04005638
• Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia PatientsRecruitingNCT03998059
• Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and InflammationRecruitingNCT03848923
• Bleeding In Thrombocytopenia ExplainedRecruitingNCT03505086
• Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP)RecruitingNCT02821572
• Pharmacogenomics of Heparin-Induced ThrombocytopeniaRecruitingNCT02717039
• The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEniaRecruitingNCT02707497Phase 2/3
• Screening for Hematology Branch ProtocolsEnrolling by invitationNCT00001620
• Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in AdultsCompletedNCT05422365Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune ThrombocytopeniaCompletedNCT04687072Phase 3Results posted
• Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or RomiplostimCompletedNCT04638829Phase 4Results posted
• A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)TerminatedNCT04596995Phase 3Results posted
• Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe ThrombocytopeniaTerminatedNCT04543279Phase 2Results posted
• Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX ChemotherapyCompletedNCT04526886Not applicableResults posted
• A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITPCompletedNCT04346654Phase 2Results posted
• A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune ThrombocytopeniaCompletedNCT04278924Phase 2Results posted
• A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune ThrombocytopeniaStatus unknownNCT04214951Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)TerminatedNCT04200456Phase 3Results posted
• A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).CompletedNCT04188379Phase 3Results posted
• Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)CompletedNCT04056195Phase 2Results posted
• XIENCE 28 USA StudyCompletedNCT03815175Not applicableResults posted
• A Pediatric Trial Using Tranexamic Acid in ThrombocytopeniaTerminatedNCT03806556Phase 1/2Results posted
• The SOLID Platelet StudyTerminatedNCT03712618Phase 2Results posted
• Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)TerminatedNCT03594045Phase 2Results posted
• Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell TransplantationCompletedNCT03513328Phase 1/2Results posted
• Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological CancersCompletedNCT03471078Phase 3Results posted
• Thrombosomes® in Bleeding Thrombocytopenic PatientsCompletedNCT03394755Phase 1Results posted
• XIENCE 28 Global StudyCompletedNCT03355742Not applicableResults posted
• Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical ProcedureTerminatedNCT03326843Phase 3Results posted
• Allogeneic Stem Cell Transplantation for Multiple Myeloma and MyelofibrosisTerminatedNCT03303950Phase 2Results posted
• A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347TerminatedNCT03275740Phase 1Results posted
• Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced ThrombocytopeniaTerminatedNCT03195010Phase 2Results posted
• Yttrium-90 Radioembolization for Cirrhosis-Associated ThrombocytopeniaTerminatedNCT03059030Not applicableResults posted
• Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative ThrombocytopeniaTerminatedNCT02964325Not applicableResults posted
• Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune ThrombocytopeniaCompletedNCT02718716Phase 2Results posted
• American Trial Using Tranexamic Acid in ThrombocytopeniaCompletedNCT02578901Phase 3Results posted
• Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02566304Phase 2Results posted
• Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT02530515Phase 2Results posted
• Prospective Study of Patients With Thrombocytopenia Following HSCTCompletedNCT02487563Phase 3Results posted
• Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive ProceduresCompletedNCT02389621Phase 3Results posted
• Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and ThrombocytopeniaCompletedNCT02335268Phase 2Results posted
• Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune ThrombocytopeniaCompletedNCT02334813Phase 3Results posted
• Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe ThrombocytopeniaCompletedNCT02298933Phase 2Results posted
• Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)CompletedNCT02279173Phase 3Results posted
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and ThrombocytopeniaCompletedNCT02227693Phase 2Results posted
• A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)TerminatedNCT02158936Phase 3Results posted
• Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved PlateletsCompletedNCT02078284Phase 1Results posted
• PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)TerminatedNCT02074436Phase 2Results posted
• Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and ThrombocytopeniaTerminatedNCT02055781Phase 3Results posted
• Study of Romiplostim for Chemotherapy Induced ThrombocytopeniaCompletedNCT02052882Phase 2Results posted
• Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective ProcedureCompletedNCT01976104Phase 3Results posted
• Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective ProcedureCompletedNCT01972529Phase 3Results posted
• Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)CompletedNCT01963260Phase 1Results posted
• A Rollover Study to Provide Continued Treatment With EltrombopagCompletedNCT01957176Phase 4Results posted
• Safety and Efficacy of Eltrombopag at Escalated DosesCompletedNCT01880047Phase 2Results posted
• Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis CTerminatedNCT01821625Phase 2/3Results posted
• Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving ChemotherapyTerminatedNCT01676961Phase 2Results posted

← Thrombocytopenia overview